Literature DB >> 12200772

Liver transplantation in association with hepatocellular carcinoma: an update of the International Tumor Registry.

Ernesto P Molmenti1, Goran B Klintmalm.   

Abstract

Hepatocellular carcinoma is an epithelial tumor derived from hepatocytes that accounts for more than 80% of all primary hepatic tumors. The severity of the underlying disease is almost always the key factor in deciding whether to consider liver resection or transplantation as its treatment. Data in our registry corresponding to almost 800 patients from transplant centers throughout the world showed that patient survival after liver transplantation was significantly affected by histologic grade, tumor size >5 cm, and the presence of positive nodes. Recurrence-free survival showed a correlation with tumor size >5 cm, positive nodes, bilobar spread, and vascular invasion. At the present time, 59% of patients in our registry are alive, 84% of whom are free of tumor. Of those who died, half did so without evidence of tumor.

Entities:  

Mesh:

Year:  2002        PMID: 12200772     DOI: 10.1053/jlts.2002.34879

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  21 in total

1.  Poor prognosis for hepatocellular carcinoma with transarterial chemoembolization pre-transplantation: retrospective analysis.

Authors:  Hai-Lin Li; Wen-Bin Ji; Rui Zhao; Wei-Dong Duan; Yong-Wei Chen; Xian-Qiang Wang; Qiang Yu; Ying Luo; Jia-Hong Dong
Journal:  World J Gastroenterol       Date:  2015-03-28       Impact factor: 5.742

2.  Role of immunosuppression and tumor differentiation in predicting recurrence after liver transplantation for hepatocellular carcinoma: a multicenter study of 412 patients.

Authors:  Thomas Decaens; Françoise Roudot-Thoraval; Solange Bresson-Hadni; Carole Meyer; Jean Gugenheim; Francois Durand; Pierre-Henri Bernard; Olivier Boillot; Philippe Compagnon; Yvon Calmus; Jean Hardwigsen; Christian Ducerf; Georges-Philippe Pageaux; Sébastien Dharancy; Olivier Chazouillères; Daniel Cherqui; Christophe Duvoux
Journal:  World J Gastroenterol       Date:  2006-12-07       Impact factor: 5.742

3.  Preoperative alpha-fetoprotein slope is predictive of hepatocellular carcinoma recurrence after liver transplantation.

Authors:  Kathy Han; George N Tzimas; Jeffrey S Barkun; Peter Metrakos; Jean L Tchervenkov; Nir Hilzenrat; Phil Wong; Marc Deschênes
Journal:  Can J Gastroenterol       Date:  2007-01       Impact factor: 3.522

4.  Liver transplantation, liver resection, and transarterial chemoembolization for hepatocellular carcinoma in cirrhosis: which is the best oncological approach?

Authors:  Georgios C Sotiropoulos; Nina Drühe; George Sgourakis; Ernesto P Molmenti; Susanne Beckebaum; Hideo A Baba; Gerald Antoch; Philip Hilgard; Arnold Radtke; Fuat H Saner; Silvio Nadalin; Andreas Paul; Massimo Malagó; Christoph E Broelsch; Hauke Lang
Journal:  Dig Dis Sci       Date:  2008-12-05       Impact factor: 3.199

5.  Current management of hepatocellular cancer.

Authors:  Bernardino Rampone; Beniamino Schiavone; Giuseppe Confuorto
Journal:  Curr Oncol Rep       Date:  2010-05       Impact factor: 5.075

Review 6.  HCC: current surgical treatment concepts.

Authors:  F Cauchy; D Fuks; J Belghiti
Journal:  Langenbecks Arch Surg       Date:  2012-06       Impact factor: 3.445

Review 7.  What is the role of adjuvant therapy after liver transplantation for hepatocellular carcinoma?

Authors:  Christophe Duvoux; Tetsuya Kiuchi; Bernhard Pestalozzi; Ronald Busuttil; Rebecca Miksad
Journal:  Liver Transpl       Date:  2011-10       Impact factor: 5.799

8.  Liver targeted therapies for hepatocellular carcinoma prior to transplant: contemporary management strategies.

Authors:  Mustafa Nazzal; Sameer Gadani; Abdullah Said; Mandy Rice; Obi Okoye; Ahmad Taha; Krista L Lentine
Journal:  Glob Surg       Date:  2018-02-15

9.  Pre-liver transplant biopsy in hepatocellular carcinoma: a potential criterion for exclusion from transplantation?

Authors:  Richard S Young; Mohammed Aldiwani; Abdul R Hakeem; Amit Nair; Ashley Guthrie; Judy Wyatt; Darren Treanor; Gareth Morris-Stiff; Rebecca L Jones; K Rajendra Prasad
Journal:  HPB (Oxford)       Date:  2012-12-27       Impact factor: 3.647

10.  Intent-to-treat analysis of liver transplant for hepatocellular carcinoma in the MELD era: impact of hepatitis C and advanced status.

Authors:  Zhenhua Hu; Zhiwei Li; Jie Xiang; Jie Zhou; Sheng Yan; Jian Wu; Lin Zhou; Shusen Zheng
Journal:  Dig Dis Sci       Date:  2014-07-10       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.